Analyst Rating
based on 15 analysts
46.67%
Buy
6.67%
Hold
46.67%
Sell
Based on 15 analysts offering long term price targets for Laurus Labs Ltd. An average target of ₹399.47
Source: S&P Global Market Intelligence
Laurus Labs Ltd Share analysis
Laurus Labs Ltd price forecast by 15 analysts
Downside of
High
₹516
Target
₹399.47
Low
₹250
Laurus Labs Ltd target price ₹399.47, a slight downside of -20.32% compared to current price of ₹485.4. According to 15 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Laurus Labs Ltd revenue growth forecast
Expected growth rate Q1, FY2026:32.79%
Forecast
Actual
Including amortisation and stock based compensations
Laurus Labs Ltd EPS growth forecast
EPS estimate Q1, FY2026:304.36%
Forecast
Actual
Source: S&P Global Market Intelligence
Performance
Day's Low
Day's High
₹477.15₹50252 Week's Low
52 Week's High
₹349.4₹518
| Returns % | |
| 1 Month Return | + 14.82 % |
| 3 Month Return | + 17.07 % |
| 1 Year Return | + 27.34 % |
| Market Stats | |
| Previous Close | ₹501.35 |
| Open | ₹501.45 |
| Volume | 25.28L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹27,030.75Cr |
Key Statistics
| P/E Ratio | 182.31 |
| PEG Ratio | -23.62 |
| Market Cap | ₹27,030.75 Cr |
| P/B Ratio | 5.02 |
| EPS | 3.12 |
| Dividend Yield | 0.2 |
| Sector | Pharmaceuticals |
| ROE | 5.41 |
Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| HOLD | ₹27,030.75 Cr | 124.4% | 0.67 | ₹168 Cr | ₹5,040 Cr | |
| HOLD | ₹27,441.61 Cr | 33.21% | 0.55 | ₹362 Cr | ₹2,226 Cr | |
| HOLD | ₹74,331.77 Cr | 45.57% | 0.56 | ₹1,811 Cr | ₹12,667 Cr | |
| BUY | ₹9,341.71 Cr | 9.36% | 0.64 | ₹119 Cr | ₹547 Cr | |
| BUY | ₹4,533.01 Cr | 16.24% | 0.54 | ₹69 Cr | ₹571 Cr |
Company Information
Share Price: ₹485.40 per share as on 18 Sep, 2024 04:01 PM
Market Capitalisation: ₹27,030.75Cr as of today
Revenue: ₹1,194.91Cr as on June 2024 (Q2 24)
Net Profit: ₹12.21Cr as on June 2024 (Q2 24)
Listing date: 19 Dec, 2016
Chairperson Name: M V G Rao
| Organisation | Laurus Labs Ltd |
| Headquarters | Hyderabad |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Laurus Labs Ltd
Laurus Labs Opens New R&D Centre in Telangana - 17 Sep, 2024
Laurus Labs has inaugurated a new R&D centre in Genome Valley with an investment of Rs 250 crore, aiming to enhance its CDMO business and create over 800 jobs.
Laurus Labs Launches New R&D Facility in Hyderabad - 16 Sep, 2024
Laurus Labs inaugurated a new ₹250 crore R&D center in Hyderabad's Genome Valley, aimed at enhancing its CDMO business and creating 800 jobs. This facility marks the company's fifth R&D center, emphasizing its commitment to innovation and addressing unmet medical needs.
Laurus Labs Passes USFDA Inspection Successfully - 14 Sep, 2024
Laurus Labs' API manufacturing facility in Hyderabad successfully cleared a USFDA inspection with zero 483 observations, enhancing its capability to deliver high-quality pharmaceutical solutions.
Laurus Labs Completes Successful FDA Audit - 13 Sep, 2024
Laurus Labs' API manufacturing facility in Hyderabad successfully completed a U.S. FDA audit from September 9-13, 2024, with zero observations, enhancing its compliance and quality assurance.
Laurus Labs Breaks Resistance, Targets Set for Gains - 11 Sep, 2024
Laurus Labs has broken above the crucial resistance level of Rs501.30, indicating strong upward momentum. With targets of Rs532.50 and Rs540+, the trend appears favorable for continued gains, while a stop loss at Rs494 is advised to manage risk.
Laurus Labs Gains from U.S. Legislation Impact - 10 Sep, 2024
Laurus Labs shares increased by 3.5% as the U.S. legislation to limit sourcing from Chinese biotech firms boosts confidence in Indian pharmaceutical companies.
Laurus Labs Faces Profit Booking After Surge - 06 Sep, 2024
Laurus Labs shares are experiencing profit booking after reaching ₹500, a 52-week high. Despite a recent 14% rally, analysts suggest buying on dips, with targets of ₹570-₹610. The stock remains bullish with a positive technical outlook.
Laurus Labs Ltd Sees Notable Stock Surge - 05 Sep, 2024
Laurus Labs Ltd shares rose 4.39% to Rs 496.5, marking a 21.9% increase over the past year. The stock has gained 17.43% in the last month and is experiencing its third consecutive day of growth, with trading volume significantly above average.
Insights on Laurus Labs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 6.68% to 9.18% in Jun 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 83.3% return, outperforming this stock by 55.9%
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 146.7% return, outperforming this stock by 167.5%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 35.07% to 33.59% in Jun 2024 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 75.61 Cr → 12.51 Cr (in ₹), with an average decrease of 83.5% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 1.45K Cr → 1.19K Cr (in ₹), with an average decrease of 17.9% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 years, LAURUSLABS stock has moved down by -20.8%
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 25.97% to 25.67% in Jun 2024 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 27.19% to 27.18% in Jun 2024 quarter
Company Financials
Index Inclusions
Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 27.18% | ||
| Foreign Institutions | 25.67% | ||
| Mutual Funds | 9.18% | 37.44 | |
| Retail Investors | 33.59% | ||
| Others | 4.38% |
Key Indicators
Laurus Labs Ltd Valuation
Laurus Labs Ltd in the last 5 years
Lowest (16.96x)
March 28, 2023
Industry (58.70x)
September 17, 2024
Today (182.31x)
September 17, 2024
Highest (193.71x)
September 18, 2020
Earnings and Dividends
Laurus Labs Ltd Earnings Results
Laurus Labs Ltd’s net profit fell -49.66% since last year same period to ₹12.51Cr in the Q1 2024-2025. On a quarterly growth basis, Laurus Labs Ltd has generated -83.45% fall in its net profits since last 3-months.
Read More about Earnings ResultsLaurus Labs Ltd Dividends April,2024
In the quarter ending March 2024, Laurus Labs Ltd has declared dividend of ₹0.40 - translating a dividend yield of 0.40%.
Read More about Dividends
Technicals Summary
Bearish
Neutral
Bullish
Laurus Labs Ltd is currently in a Bullish trading position according to technical analysis indicators.
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Laurus Labs Ltd shares.
Laurus Labs Ltd (LAURUSLABS) share price today is ₹485.4
Laurus Labs Ltd is listed on NSE
Laurus Labs Ltd is listed on BSE
- Today’s highest price of Laurus Labs Ltd is ₹502.
- Today’s lowest price of Laurus Labs Ltd is ₹477.15.
PE Ratio of Laurus Labs Ltd is 182.31
PE ratio = Laurus Labs Ltd Market price per share / Laurus Labs Ltd Earnings per share
Today’s traded volume of Laurus Labs Ltd(LAURUSLABS) is 25.28L.
Today’s market capitalisation of Laurus Labs Ltd(LAURUSLABS) is ₹27030.75Cr.
| Laurus Labs Ltd(LAURUSLABS | Price |
|---|---|
52 Week High | ₹518 |
52 Week Low | ₹349.4 |
Laurus Labs Ltd(LAURUSLABS) share price is ₹485.4. It is down -6.29% from its 52 Week High price of ₹518
Laurus Labs Ltd(LAURUSLABS) share price is ₹485.4. It is up 38.92% from its 52 Week Low price of ₹349.4
| Laurus Labs Ltd(LAURUSLABS | Returns |
|---|---|
1 Day Returns | -15.95% |
1 Month Returns | 14.82% |
3 Month Returns | 17.07% |
1 Year Returns | 27.34% |